arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Abivax SA

ABVX Health Care Biotechnology: Pharmaceutical Preparations
$125.41
▲ +0.0% Today
as of Aug 5, 16:45 ET
Last 30 days +30.41% Jun 29 → Aug 05
$92.27 $106.33 $120.40 $134.46 $148.53 Jun 29 Jul 07 Jul 14 Jul 22 Jul 29 Aug 05
Open
$105.18
High
$108.16
Low
$98.23
Volume
$3M
Avg Vol
$1M
Mkt Cap
$10.7B
P/E (TTM)
—
Beta
—
52w High
$148.83
52w Low
$5.69
Div Yield
—
Shares Out
—

Recent Press Releases & News last 60 days · 25 items

Jul 30 · 20:05 PR GlobeNewswire
Abivax Announces Positive Pre-NDA Interaction with the FDA for Obefazimod
Jul 26 · 08:07 Simply Wall St.
ABIVAX Société Anonyme (ENXTPA:ABVX) Adds Commercial Leaders, Is The Upside Already Priced In?
Jul 25 · 10:07 Simply Wall St.
Abivax (ENXTPA:ABVX) Adds Commercial Leaders And Signs Valerio R And D Deal
▸ Show all 25 press releases & news Free account →

Overview

52-week range
$5.69
$149
84% of range
Avg surprise (last 3)
+7.9%
Avg reaction (last 2)
+1.9%
50% positive
Latest IV / EM
81%
EM ±4.8% · $125 · Aug 7

Earnings trends

EPS — actual vs estimate Actual Estimate
$-1.07$-0.98$-0.89$-0.80$-0.71 Actual $-0.87Est $-0.76Actual $-0.86Est $-0.90Actual $-0.71Est $-1.07 Mar/2025Jun/2025Mar/2026

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Fri May 22, 2026Mar/2026 $-0.71 $-1.07 +33.6% +18.4% -1.6% earnings
Mon Sep 8, 2025Jun/2025 $-0.86 $-0.90 +4.4% — — earnings
Mon Jun 2, 2025Mar/2025 $-0.87 $-0.76 -14.5% — +5.5% earnings

Implied volatility — last 90 days

48%92%136%180%224% Jun 07 — IV 122% · EM ±11.4%Jun 08 — IV 118% · EM ±9.8%Jun 09 — IV 116% · EM ±8.4%Jun 10 — IV 117% · EM ±6.9%Jun 11 — IV 113% · EM ±4.7%Jun 15 — IV 103% · EM ±7.4%Jun 16 — IV 114% · EM ±6.8%Jun 17 — IV 195% · EM ±8.2%Jun 19 — IV 156% · EM ±17.2%Jun 22 — IV 196% · EM ±16.4%Jun 23 — IV 186% · EM ±13.5%Jun 24 — IV 225% · EM ±13.3%Jun 25 — IV 207% · EM ±8.6%Jun 29 — IV 138% · EM ±32.6%Jun 30 — IV 83% · EM ±19.4%Jul 01 — IV 66% · EM ±2.8%Jul 03 — IV 72% · EM ±7.9%Jul 06 — IV 64% · EM ±5.3%Jul 07 — IV 49% · EM ±3.5%Jul 08 — IV 65% · EM ±3.8%Jul 09 — IV 72% · EM ±3.0%Jul 13 — IV 61% · EM ±5.1%Jul 14 — IV 52% · EM ±3.8%Jul 15 — IV 63% · EM ±3.7%Jul 16 — IV 125% · EM ±5.2%Jul 20 — IV 73% · EM ±6.1%Jul 21 — IV 72% · EM ±5.2%Jul 22 — IV 68% · EM ±4.0%Jul 23 — IV 181% · EM ±7.6%Jul 27 — IV 74% · EM ±6.2%Jul 28 — IV 75% · EM ±5.5%Jul 29 — IV 61% · EM ±3.6%Jul 30 — IV 78% · EM ±3.2%Aug 03 — IV 81% · EM ±6.8%Aug 04 — IV 75% · EM ±5.4%Aug 05 — IV 81% · EM ±4.8%

Sector peers

LLY
Eli Lilly and Company
$1.1T $1,164.75-0.4%
JNJ
Johnson & Johnson
$624.1B $258.23+0.2%
ABBV
AbbVie Inc.
$454.8B $246.35+0.1%
MRK
Merck & Company, Inc.
$321.6B $129.20+0.7%
PM
Philip Morris International Inc
$299.3B $188.93-0.0%
NVS
Novartis AG
$297.9B $154.440.0%
View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in